West Pharmaceutical Services Says Q1 Adjusted Earnings Per Share $1.01.

WEST ANNOUNCES FIRST-QUARTER 2020 RESULTS.
SEES FY 2020 ADJUSTED EARNINGS PER SHARE $3.52 TO $3.62.
Q1 ADJUSTED EARNINGS PER SHARE $1.01.
Q1 EARNINGS PER SHARE $0.99.
Q1 EARNINGS PER SHARE ESTIMATE $0.82 -- REFINITIV IBES DATA.
SEES FY 2020 SALES $1.95 BILLION TO $1.97 BILLION.
Q1 SALES $491.5 MILLION VERSUS REFINITIV IBES ESTIMATE OF $466.8 MILLION.
FY2020 EARNINGS PER SHARE VIEW $3.39, REVENUE VIEW $1.94 BILLION -- REFINITIV IBES DATA.ORGANIC SALES GROWTH IS EXPECTED TO BE APPROXIMATELY 8% IN 2020.NET SALES GUIDANCE INCLUDES AN ESTIMATED FULL-YEAR HEADWIND OF $26 MILLION FOR FULL-YEAR 2020.